Charter of the Transmissible Spongiform Encephalopathies Advisory Committee

Charter of the Transmissible Spongiform Encephalopathies Advisory Committee
Authority

The Transmissible Spongiform Encephalopathies Advisory Committee was established under 15 U.S.C. 1451 et seq.; 21 U.S.C. 321, 341, 342, 343, 343-1, 344, 345, 346, 348, 349, 350, 350a, 351, 352, 353(f), 355, 360b, 360c-j, 371, 375, 376, 378, 379e, 381, 393, 394, 881(b); 42 U.S.C. 217a, 241, 242, 242a, 262, 264; 21 CFR Part 14, 330.10(a); Pub. L. 92-463 (5 U.S.C. App.), the Federal Advisory Committee Act, which sets forth standards for the formation and use of advisory committees.

Objectives and Scope of Activities

The Transmissible Spongiform Encephalopathies Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.


open here to see the full-text (large):
Charter of the Transmissible Spongiform Encephalopathies Advisory Committee